What is the management plan for food protein-induced enterocolitis (FPIES)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Food Protein-Induced Enterocolitis Syndrome (FPIES)

The primary management of FPIES involves strict dietary elimination of trigger foods, appropriate emergency treatment of acute reactions, and regular monitoring for resolution under medical supervision. 1

Diagnosis and Initial Management

  • FPIES typically presents with protracted, projectile vomiting 1-4 hours after ingesting trigger foods, sometimes followed by diarrhea within 24 hours
  • In 15-20% of severe cases, patients may develop hypovolemic or distributive shock 2
  • Common triggers include cow's milk, soy, rice, oat, avocado, egg, and peanut 2

Dietary Management

Elimination Diet

  • Complete elimination of identified trigger foods is the cornerstone of FPIES management 1
  • For cow's milk or soy-induced FPIES:
    • Avoid all forms including baked and processed foods
    • Goat and sheep milk are not recommended due to protein sequence homology
    • Introduction of baked milk/egg should only be done under physician supervision 1

Formula and Breastfeeding Recommendations

  • Infants with cow's milk/soy-induced FPIES can be:
    • Breastfed (preferred when possible)
    • Given casein-based extensively hydrolyzed formula
    • 10-20% may require amino acid-based formula (AAF) 1
  • For infants with cow's milk-induced FPIES, introduction of soy formula should only be done under medical supervision (and vice versa) due to 20-40% co-reactivity risk in US patients 1

Maternal Diet During Breastfeeding

  • Do not recommend routine maternal dietary elimination if the infant is thriving and asymptomatic 1
  • Only eliminate trigger foods from maternal diet if:
    • Reactions occur after breastfeeding
    • Infant has failure to thrive
    • Nutritional consultation should be considered to assist with elimination diet 1

Management of Acute FPIES Episodes

Home Management

  • For mild episodes (1-2 episodes of emesis with no/mild lethargy):

    • Attempt oral rehydration at home with breast milk or clear fluids
    • For children with history of severe reactions, seek emergency care even with mild symptoms 1
  • For moderate-to-severe episodes (>3 episodes of emesis with moderate-to-severe lethargy):

    • Call 911 or go to emergency department immediately 1

Medical Facility Management

Based on severity of presentation:

  1. Mild (1-2 episodes of emesis, no lethargy):

    • Oral rehydration
    • Consider ondansetron 0.15 mg/kg IM (max 16 mg) if ≥6 months old
    • Monitor for 4-6 hours from onset 1
  2. Moderate (>3 episodes of emesis with mild lethargy):

    • Ondansetron 0.15 mg/kg IM (max 16 mg) if >6 months old
    • Consider IV line for normal saline bolus (20 mL/kg)
    • Transfer to ED/ICU if persistent hypotension, shock, lethargy, or respiratory distress 1
  3. Severe (>3 episodes of emesis with severe lethargy, hypotonia, ashen/cyanotic appearance):

    • IV line with rapid normal saline bolus (20 mL/kg), repeat as needed
    • IV ondansetron 0.15 mg/kg (max 16 mg) if ≥6 months old
    • If IV access difficult, give ondansetron IM
    • Consider IV methylprednisolone 1 mg/kg (max 60-80 mg)
    • Monitor and correct acid-base and electrolyte abnormalities
    • Correct methemoglobinemia if present
    • Monitor vital signs
    • Discharge after 4-6 hours when stable and tolerating oral fluids 1

Ondansetron Use in FPIES

  • Ondansetron (0.15 mg/kg, max 16 mg) is effective for stopping emesis during acute FPIES reactions 1, 3
  • Use with caution in children with heart disease due to potential QT interval prolongation 1, 3
  • Administration route:
    • IV preferred in emergency settings
    • IM if IV access is difficult
    • Oral can be considered for less severe cases 3

Long-term Follow-up and Monitoring

  • Nutritional consultation is strongly recommended for all patients to ensure:

    • Adherence to dietary avoidance
    • Adequate nutrition despite restrictions 1
  • Food challenges to assess for resolution should be performed:

    • In hospital setting with IV access for patients with history of severe FPIES
    • In physician's office for those without history of severe reactions
    • Under physician supervision when introducing potential cross-reactive foods 1

Prognosis

  • Natural history of infantile FPIES is generally favorable, with most cases resolving by age 3-5 years
  • Exception: fish FPIES in children and seafood FPIES in adults have lower resolution rates 2

Common Pitfalls and Caveats

  • FPIES is frequently misdiagnosed as infectious gastroenteritis, sepsis, or other conditions 4
  • No specific biomarkers exist for diagnosis; it relies on clinical recognition 2
  • Testing for food-specific IgE is usually negative, though some patients (especially with cow's milk FPIES) may develop IgE sensitization over time, which tends to indicate a more prolonged course 5
  • Brief resolved unexplained events (BRUE) may be confused with FPIES; key differentiating factors are presence of vomiting and duration >1 minute in FPIES 6

By following these guidelines, clinicians can effectively manage FPIES, minimize morbidity, and improve quality of life for affected patients.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antiemetic Therapy in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Food Protein-Induced Enterocolitis Syndrome.

Journal of investigational allergology & clinical immunology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.